Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC131453-Deazaneplanocin,DZNepCAS: 102052-95-9纯度: >98.00%
An inhibitor of lysine methyltransferase EZH2
- GC13152SIN-1 chlorideCAS: 16142-27-1纯度: >99.00%
SIN- 1 (chloride) is a potent vasorelaxant and inhibitor of platelet aggregation.
- GC13154Pim1/AKK1-IN-1CAS: 1093222-27-5纯度: >98.00%
Pim1/AKK1-IN-1是一种有效的多靶点抑制剂,对Pim1、AKK1(AAK1)、LKB1和MST2等激酶具有抑制作用。
- GC13166OmeprazoleCAS: 73590-58-6纯度: >98.00%
Omeprazole是一种胃H + /K + ATPase的抑制剂(PPI),对于猪ATPase的IC 50 值为1.1μM。Omeprazole对CYP2C19活性具有竞争性抑制作用,抑制常数(Ki)为2至6μM。
- GC13204InolitazoneCAS: 223132-37-4
Inolitazone 是一种新型的高亲和力 PPARγ 激动剂,其生物活性依赖于 PPARγ,抑制生长的 IC50 为 0.8 nM。
- GC13227LRGILS-NH2CAS: 245329-01-5
LRGILS-NH2 是一种反向序列蛋白酶激活受体-2 (PAR-2)-失活的阴性对照,SLIGRL-NH2 是一种 PAR-2 激活肽。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC13145 | 3-Deazaneplanocin,DZNep | 102052-95-9 | >98.00% | |
An inhibitor of lysine methyltransferase EZH2 | ||||
| GC13146 | Amlodipine Besylate | 111470-99-6 | >99.50% | |
An L-type calcium channel blocker | ||||
| GC13152 | SIN-1 chloride | 16142-27-1 | >99.00% | |
SIN- 1 (chloride) is a potent vasorelaxant and inhibitor of platelet aggregation. | ||||
| GC13154 | Pim1/AKK1-IN-1 | 1093222-27-5 | >98.00% | |
Pim1/AKK1-IN-1是一种有效的多靶点抑制剂,对Pim1、AKK1(AAK1)、LKB1和MST2等激酶具有抑制作用。 | ||||
| GC13159 | Piromidic Acid | 19562-30-2 | >98.00% / >99.00% | |
A quinolone antibiotic | ||||
| GC13161 | Escitalopram | 128196-01-0 | - | |
Escitalopram是一种高选择性的5-羟色胺再摄取抑制剂(K i =0.89nM)。 | ||||
| GC13162 | Prilocaine hydrochloride | 1786-81-8 | - | |
An Analytical Reference Standard | ||||
| GC13164 | Ampalex | 154235-83-3 | >99.50% | |
An AMPA receptor modulator | ||||
| GC13166 | Omeprazole | 73590-58-6 | >98.00% | |
Omeprazole是一种胃H + /K + ATPase的抑制剂(PPI),对于猪ATPase的IC 50 值为1.1μM。Omeprazole对CYP2C19活性具有竞争性抑制作用,抑制常数(Ki)为2至6μM。 | ||||
| GC13173 | Sotalol | 3930-20-9 | - | |
An Analytical Reference Standard | ||||
| GC13197 | Praziquantel | 55268-74-1 | >99.50% / >98.00% | |
An anthelmintic agent | ||||
| GC13198 | AMG-900 | 945595-80-2 | >98.00% | |
A selective pan-Aurora kinase inhibitor | ||||
| GC13202 | D4476 | 301836-43-1 | >98.00% | |
Inhibitor of CK1 and ALK5 | ||||
| GC13204 | Inolitazone | 223132-37-4 | - | |
Inolitazone 是一种新型的高亲和力 PPARγ 激动剂,其生物活性依赖于 PPARγ,抑制生长的 IC50 为 0.8 nM。 | ||||
| GC13206 | Nicotinic Acid | 59-67-6 | >99.50% | |
烟酸(维生素 B3)是一种具有口服活性的水溶性维生素 B3,是人体必需的营养素。 | ||||
| GC13207 | Butenafine HCl | 101827-46-7 | >98.00% | |
An antifungal agent | ||||
| GC13208 | PR-619 | 2645-32-1 | >98.50% / >98.00% | |
PR-619是一种广谱的去泛素酶抑制剂。 | ||||
| GC13215 | Ascomycin(FK 520) | 104987-12-4 | >99.50% | |
A potent macrolide immunosuppressant | ||||
| GC13218 | TRPC6 inhibitor | 1333207-63-8 | - | |
A TRPC6 channel blocker | ||||
| GC13223 | Aliskiren Hemifumarate | 173334-58-2 | >98.50% | |
A nonpeptide renin inhibitor | ||||
| GC13227 | LRGILS-NH2 | 245329-01-5 | - | |
LRGILS-NH2 是一种反向序列蛋白酶激活受体-2 (PAR-2)-失活的阴性对照,SLIGRL-NH2 是一种 PAR-2 激活肽。 | ||||
| GC13237 | LMK 235 | 1418033-25-6 | >99.50% | |
A selective inhibitor of HDAC4 and HDAC5 | ||||
| GC13253 | Anamorelin | 249921-19-5 | >99.50% | |
A small molecule agonist of GHS-R1a | ||||
| GC13257 | AC480 (BMS-599626) | 714971-09-2 | - | |
A dual inhibitor of EGFR and HER2 | ||||
